Work

Disease Burden on PET Predicts Outcomes for Advanced NSCLC Patients Treated with First-Line Immunotherapy

Year: 2022

Type: article

Study design: Observational Study

Source: Clinical Lung Cancer

DOI: 10.1016/j.cllc.2022.02.003

Authors: Therese Y. Andraos, Balazs Halmos, Haiying Cheng, Calvin Huntzinger, Shervin M. Shirvani, Nitin Ohri

Institutions: Albert Einstein College of Medicine, Montefiore Medical Center, RefleXion Medical (United States)

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Bayer, Spectrum Pharmaceuticals, RefleXion Medical

OpenAlex ID: W4214932197

FWCI: 0.843

Cites: 20

Cited by: 7

Related to: 10